Skip to main content
logo
Alligator Bioscience AB (publ) (STO:ATORX)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1696
-0.0024 (-1.40%)
At close: Mar 27, 2026

Alligator Bioscience AB Revenue

In the year 2025, Alligator Bioscience AB had annual revenue of 4.42M SEK, down -92.34%. Alligator Bioscience AB had revenue of 47.00K in the quarter ending December 31, 2025, a decrease of -99.89%.

Revenue
4.42M
Revenue Growth
-92.34%
P/S Ratio
24.08
Revenue / Employee
402.09K
Employees
11
Market Cap
106.53M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.42M-53.30M-92.34%
Dec 31, 202457.72M-1.53M-2.58%
Dec 31, 202359.25M23.25M64.58%
Dec 31, 202236.00M22.67M170.14%
Dec 31, 202113.33M7.81M141.65%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Magle Chemoswed Holding AB296.57M
Xbrane Biopharma AB152.35M
IRLAB Therapeutics AB57.46M
Alzinova AB26.80M
Scandinavian ChemoTech AB12.29M
Biovica International AB10.93M
NextCell Pharma AB9.83M
Biosergen AB2.09M
Revenue Rankings

Alligator Bioscience AB News

More News